Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor.
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D004298:Dopamine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004594:Electrophysiology; D005260:Female; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects; D008055:Lipids / Q000502:physiology; D008564:Membrane Potentials / Q000502:physiology; D008845:Microinjections; D009865:Oocytes / Q000187:drug effects / Q000502:physiology; D018408:Patch-Clamp Techniques; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology; D010766:Phosphorylation; D011247:Pregnancy; D011493:Protein Kinase C / Q000187:drug effects*; D011522:Protons; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects* / Q000378:metabolism; D014982:Xenopus laevis
D001095:Arachidonic Acids; D008055:Lipids; D011522:Protons; D011955:Receptors, Drug; C474941:arachidonyl dopamine; D015240:Phorbol 12,13-Dibutyrate; D011493:Protein Kinase C; D004298:Dopamine